Cargando…
Depression and anxiety in glioma patients
Glioma patients carry the burden of having both a progressive neurological disease and cancer, and may face a variety of symptoms, including depression and anxiety. These symptoms are highly prevalent in glioma patients (median point prevalence ranging from 16–41% for depression and 24–48% for anxie...
Autores principales: | van der Meer, Pim B, Dirven, Linda, Hertler, Caroline, Boele, Florien W, Batalla, Albert, Walbert, Tobias, Rooney, Alasdair G, Koekkoek, Johan A F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346395/ https://www.ncbi.nlm.nih.gov/pubmed/37457222 http://dx.doi.org/10.1093/nop/npad019 |
Ejemplares similares
-
Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints
por: van der Meer, Pim B., et al.
Publicado: (2021) -
Family caregiver constructs and outcome measures in neuro-oncology: A systematic review
por: Boele, Florien, et al.
Publicado: (2022) -
Retention rates of antiepileptic drugs in glioma patients: the most appropriate outcome
por: van der Meer, Pim B, et al.
Publicado: (2020) -
Psychiatric symptoms in glioma patients: from diagnosis to management
por: Boele, Florien W, et al.
Publicado: (2015) -
First‐line levetiracetam versus enzyme‐inducing antiseizure medication in glioma patients with epilepsy
por: van der Meer, Pim B., et al.
Publicado: (2022)